If a crappy drug like pristiq can make money, Viibryd will too. Anyone saying it is crap is purely stating their opinion, it may take time, but it will succeed.
Daliresp is a completely new entry, it will take time for the docs to change the their approach to treating COPD. This medication needs RUD info to show what preventing an exacerbation can do for the bottom line and the reps need to hit home on what the benefit means to the patient, the doc, and their families.
These are good medications worthy of being prescribed. If you are a rep and don't believe in your drug, you will fail.